Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Palatin Technologies Inc PTN

Healthcare Biotechnology
Palatin Technologies, Inc. is a biopharmaceutical company. The Company is engaged in developing medicines based on molecules that modulate the activity of the melanocortin receptor systems, with targeted, receptor-specific product candidates for the treatment of diseases with unmet medical need and commercial potential. Its new product development activities focus primarily on MC1r agonists... see more

Recent & Breaking News (NYSEAM:PTN)

Palatin Technologies, Inc. To Report Fourth Quarter and Fiscal Year 2014 Results

PR Newswire September 4, 2014

Palatin Technologies Licenses Bremelanotide in Europe and Other Selected Countries to Richter

PR Newswire September 3, 2014

Palatin Technologies Announces Notification of Patent Allowance On Melanocortin Receptor-1 Specific Peptides

PR Newswire July 9, 2014

Palatin Technologies to Join Russell Microcap Index

PR Newswire June 27, 2014

Palatin Technologies Announces Notification of Patent Allowance On Next Generation Melanocortin Receptor-Specific Peptides

PR Newswire June 10, 2014

Palatin Technologies, Inc. Reports Third Quarter Fiscal Year 2014 Results; Teleconference and Webcast to be held on May 13, 2014

PR Newswire May 13, 2014

Palatin Technologies, Inc. To Report Third Quarter Fiscal Year 2014 Results

PR Newswire May 9, 2014

Palatin Technologies Presents at the American Psychiatric Association (APA)

PR Newswire May 6, 2014

Palatin Technologies Announces Option Exercise by Specialty Pharmaceutical Company to License Bremelanotide in Europe

PR Newswire May 1, 2014

Palatin Technologies Presents at the Annual Clinical Meeting of the American College of Obstetricians and Gynecologists (ACOG)

PR Newswire April 29, 2014

Palatin Technologies Announces Option Extension for License to Bremelanotide in Europe

PR Newswire March 31, 2014

Palatin Technologies To Present At The 26Th Annual ROTH Conference

PR Newswire March 6, 2014

Palatin Technologies Presents Positive New Data Analyses Demonstrating Efficacy of Bremelanotide in Female Hypoactive Sexual Desire Disorder

PR Newswire February 24, 2014

Palatin Technologies, Inc. Reports Second Quarter Fiscal Year 2014 Results; Teleconference and Webcast to be held on February 18, 2014

PR Newswire February 18, 2014

Palatin Technologies, Inc. To Report Second Quarter Fiscal Year 2014 Results

PR Newswire February 13, 2014

Palatin Technologies to Present at the 16th Congress of the European Society for Sexual Medicine

PR Newswire January 30, 2014

Palatin Technologies, Inc. Receives $1.85 Million from Sale of New Jersey State Tax Credits

PR Newswire January 23, 2014

Palatin Technologies to Present at "TEN", Noble Financial Capital Markets' Tenth Annual Equity Conference

PR Newswire January 16, 2014

Palatin Technologies Responds to Unusual Market Activity

PR Newswire January 13, 2014

LifeSci Advisors Initiates Coverage of Palatin Technologies, INC.

Marketwired January 8, 2014